Altimmune (LTS:0A4C) Accounts Payable : $3.76 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Altimmune Accounts Payable?

Altimmune's Accounts Payable for the quarter that ended in Mar. 2024 was $3.76 Mil.

Altimmune's quarterly Accounts Payable declined from Sep. 2023 ($3.05 Mil) to Dec. 2023 ($2.07 Mil) but then increased from Dec. 2023 ($2.07 Mil) to Mar. 2024 ($3.76 Mil).

Altimmune's annual Accounts Payable increased from Dec. 2021 ($2.03 Mil) to Dec. 2022 ($4.80 Mil) but then declined from Dec. 2022 ($4.80 Mil) to Dec. 2023 ($2.07 Mil).

Altimmune Accounts Payable Historical Data

The historical data trend for Altimmune's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Altimmune Accounts Payable Chart

Altimmune Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

0.02

0.61

2.03

4.80

2.07

Altimmune Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable	Get a 7-Day Free Trial															5.24	4.04	3.05	2.07	3.76

Altimmune Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Altimmune Accounts Payable Related Terms

Thank you for viewing the detailed overview of Altimmune's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Altimmune (LTS:0A4C) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Altimmune Inc (LTS:0A4C) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

ALT:USA ALT1:Mexico 3G0:Germany

Address

910 Clopper Road, Suite 201S, Gaithersburg, MD, USA, 20878

Website

https://www.altimmune.com

Altimmune Inc is engaged on developing treatments for obesity and liver diseases. The Company's pipeline includes next generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

Altimmune (LTS:0A4C) Headlines

No Headlines